Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTCX NASDAQ:CTSO NASDAQ:IINN NASDAQ:MDAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTCXCarmell$2.70-4.6%$3.01$0.17▼$1.27$56.44M0.514.65 million shs20,694 shsCTSOCytosorbents$1.06-11.7%$1.06$0.71▼$1.61$66.53M1.19192,541 shs170,505 shsIINNInspira Technologies OXY B.H.N.$1.28+6.7%$1.08$0.40▼$1.65$16.15M2.3925,543 shs231,677 shsMDAISpectral AI$2.23-5.5%$2.39$0.82▼$3.25$56.46M0.9540,872 shs853,593 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTCXCarmell0.00%-4.59%+0.75%+2,025.98%+157.14%CTSOCytosorbents+20.00%+31.71%+13.21%+37.93%+14.29%IINNInspira Technologies OXY B.H.N.+7.62%-8.40%0.00%+114.29%+22.45%MDAISpectral AI-3.28%-2.48%-17.48%+66.20%+56.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTCXCarmellN/AN/AN/AN/AN/AN/AN/AN/ACTSOCytosorbents1.6258 of 5 stars3.32.00.00.02.00.00.6IINNInspira Technologies OXY B.H.N.2.5184 of 5 stars3.53.00.00.02.91.70.0MDAISpectral AI1.8394 of 5 stars3.52.00.00.00.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTCXCarmell 0.00N/AN/AN/ACTSOCytosorbents 2.50Moderate Buy$5.50400.00% UpsideIINNInspira Technologies OXY B.H.N. 3.00Buy$2.0062.60% UpsideMDAISpectral AI 3.00Buy$3.5059.09% UpsideCurrent Analyst Ratings BreakdownLatest IINN, MDAI, CTCX, and CTSO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.007/21/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.006/25/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.006/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$2.005/15/2025CTSOCytosorbentsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.005/15/2025CTSOCytosorbentsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTCXCarmell$32.84K1,718.79N/AN/A$1.07 per share2.52CTSOCytosorbents$35.60M1.94N/AN/A$0.20 per share5.50IINNInspira Technologies OXY B.H.N.N/AN/AN/AN/A$0.34 per shareN/AMDAISpectral AI$29.58M1.88N/AN/A($0.32) per share-6.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTCXCarmell-$15.44MN/A0.00∞N/AN/A-217.50%-50.22%N/ACTSOCytosorbents-$20.72M-$0.17N/AN/AN/A-25.58%-109.15%-28.90%N/AIINNInspira Technologies OXY B.H.N.-$11.05MN/A0.00∞N/AN/AN/AN/AN/AMDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%8/12/2025 (Estimated)Latest IINN, MDAI, CTCX, and CTSO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025MDAISpectral AI-$0.07N/AN/AN/A$5.44 millionN/A8/7/2025Q2 2025CTSOCytosorbents-$0.07-$0.05+$0.02$0.03$9.79 million$9.62 million5/14/2025Q1 2025CTSOCytosorbents-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTCXCarmellN/AN/AN/AN/AN/ACTSOCytosorbentsN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTCXCarmellN/A0.310.29CTSOCytosorbents0.982.612.30IINNInspira Technologies OXY B.H.N.0.092.021.89MDAISpectral AIN/A1.411.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTCXCarmell24.22%CTSOCytosorbents32.87%IINNInspira Technologies OXY B.H.N.12.72%MDAISpectral AI67.08%Insider OwnershipCompanyInsider OwnershipCTCXCarmell29.00%CTSOCytosorbents6.60%IINNInspira Technologies OXY B.H.N.29.40%MDAISpectral AI30.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTCXCarmell1420.91 million14.84 millionNot OptionableCTSOCytosorbents22062.76 million58.62 millionOptionableIINNInspira Technologies OXY B.H.N.2012.62 million8.91 millionNot OptionableMDAISpectral AI8325.32 million17.55 millionNot OptionableIINN, MDAI, CTCX, and CTSO HeadlinesRecent News About These CompaniesSpectral AI Announces 2025 Second Quarter Financial Results2 hours ago | globenewswire.comSpectral AI Inc (MDAI) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 11 at 5:34 PM | finance.yahoo.comSpectral AI (NASDAQ:MDAI) Trading Up 1.7% - Should You Buy?August 10 at 4:36 AM | marketbeat.comSpectral AI (MDAI) to Release Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comWhy Spectral AI, Inc. (NASDAQ:MDAI) Could Be Worth WatchingAugust 2, 2025 | finance.yahoo.comSpectral AI Schedules 2025 Second Quarter Financial Results and Conference CallJuly 30, 2025 | globenewswire.comMDAI: DeepView De Novo SubmissionJuly 10, 2025 | finance.yahoo.comUSA News Group: Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for InvestorsJuly 7, 2025 | finanznachrichten.deSpectral AI, Inc.: Spectral AI Announces Submission to FDA of its DeepView SystemJune 30, 2025 | finanznachrichten.deSpectral AI Announces Submission to FDA of its DeepView® SystemJune 30, 2025 | globenewswire.comSpectral AI, Inc. (MDAI) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comA Look At The Intrinsic Value Of Spectral AI, Inc. (NASDAQ:MDAI)June 22, 2025 | finance.yahoo.comSpectral Ai Inc Share Chat (MDAI.US)June 11, 2025 | lse.co.ukDeepView® System highlighted at the annual British Burn Association conferenceJune 10, 2025 | globenewswire.comSpectral AI Announces Appointment of Stanley Micek as Chief Operating OfficerMay 30, 2025 | globenewswire.comSpectral AI Announces Voting Results from 2025 Annual Meeting of StockholdersMay 29, 2025 | globenewswire.comDeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns JournalMay 27, 2025 | finance.yahoo.comSpectral AI, Inc. (MDAI) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comSpectral AI Announces 2025 First Quarter Financial ResultsMay 13, 2025 | globenewswire.comWhat's Next: Spectral AI's Earnings PreviewMay 12, 2025 | benzinga.comBurn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meetingApril 30, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIINN, MDAI, CTCX, and CTSO Company DescriptionsCarmell NASDAQ:CTCX$2.70 -0.13 (-4.59%) As of 08/8/2025Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.Cytosorbents NASDAQ:CTSO$1.06 -0.14 (-11.67%) Closing price 04:00 PM EasternExtended Trading$1.06 +0.00 (+0.47%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.Inspira Technologies OXY B.H.N. NASDAQ:IINN$1.28 +0.08 (+6.67%) Closing price 04:00 PM EasternExtended Trading$1.21 -0.07 (-5.16%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Spectral AI NASDAQ:MDAI$2.23 -0.13 (-5.51%) Closing price 04:00 PM EasternExtended Trading$2.16 -0.07 (-3.32%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces Alphabet Reclaims $200 Threshold—Bull Run Reignited? Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% How Vertiv Is Cashing in on AI's Power Crisis CrowdStrike Faces Valuation Test Before Key Earnings Report AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun Post-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.